Embrace Moderna-ty

In this week’s stock analysis we explore two pandemic-gainers that could be back for round 2, and a wire company with eagerly-awaited earnings.

Not all pandemic gainers have crashed and burned - in fact, some stocks are well on their way back up to their previously lofty highs (although we’re still a long way from that yet). This week’s sele…